3 completed, 2 unknown. 5 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Completed 3, Unknown 2 |
| Phase 2 | 1 | Unknown 1 |
Follow Positron-Emission Tomography: new trials by email Literature Review of Positron-Emission Tomography trials Research Report on Positron-Emission Tomography
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| 68Ga-FAP-CHX PET/CT : Dosimetry and Preliminary Clinical Translational Studies 68Ga-FAP-CHX - Tumor, Positron-Emission Tomography | Phase 1 / Phase 2 | Unknown | First Affiliated Hospital of Fujian Medical University | 50 | 2022-05-01 | 2023-09-21 |
| 68Ga-NOTA Evans Blue PET/CT in Patients With Lymphatic System Related Diseases 68Ga-NOTA Evans Blue - Positron-Emission Tomography | Phase 1 | Unknown | First Affiliated Hospital of Fujian Medical University | 80 | 2021-04-25 | 2023-09-21 |
| ⁸⁹Zr-Df-IAB22M2C PET/CT in Patients With Selected Solid Malignancies or Hodgkin's Lymphoma ⁸⁹Zr-Df-IAB22M2C Infusion - Positron-Emission Tomography, Immunomodulation | Phase 1 | Completed | ImaginAb, Inc. | 15 | 2017-06-19 | 2018-09-18 |
| Evaluation of the Positron Emission Tomography (PET) Tracer ZK 6032924 in Patients With Multiple Sclerosis Compared to Healthy Volunteers F-18 FEDAA1106 (BAY85-8101) - Positron-Emission Tomography, Multiple Sclerosis | Phase 1 | Completed | Bayer | 16 | 2009-01-01 | 2014-04-02 |
| Evaluation of ZK 6032924 in Probable Alzheimer's Disease Patients Versus Healthy Volunteers and the Radiation Dosimetry of ZK 6032924 in Healthy Volunteers F-18 FEDAA1106 (BAY85-8101) - Positron-Emission Tomography, Alzheimer's Disease | Phase 1 | Completed | Bayer | 25 | 2007-06-01 | 2015-01-08 |
Neuroinflammatory Diseases (2) · Alzheimer Disease (1) · Hodgkin Disease (1) · Multiple Sclerosis (1) · Neoplasms (1)
Immune System Diseases (2) · Inflammation (2) · Nervous System Diseases (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Autoimmune Diseases (1) · Autoimmune Diseases of the Nervous System (1) · Brain Diseases (1) · Central Nervous System Diseases (1) · Dementia (1) · Demyelinating Autoimmune Diseases, CNS (1) · Demyelinating Diseases (1) · Hemic and Lymphatic Diseases (1) · Immunoproliferative Disorders (1) · Lymphatic Diseases (1)
68Ga-FAPI (1) · Fluorodeoxyglucose F18 (1)
Bayer (2) · First Affiliated Hospital of Fujian Medical University (2) · ImaginAb, Inc. (1)
China (2) · Sweden (2) · Australia (1) · Netherlands (1) · United States (1)
Weibing Miao, MD (1)
2008 (1)